Verizon’s Kyle Malady sells 1,100 shares

EVP and Group CEO–VZ Business Kyle Malady sold 1,100 Verizon shares under a pre‑arranged Rule 10b5‑1 trading plan and retained over 126,000 shares in total.

Available on EDGAR 09/09/2026 - 01:41 PM EDT Accepted by SEC EDGAR 09/09/2026 - 01:40 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

VERIZON COMMUNICATIONS INC (VZ) executive Kyle Malady, EVP and Group CEO–VZ Business, reported selling 1,100 shares of common stock on September 8, 2026 at $49.98 per share in an open‑market or private transaction. After this sale, he held 106,566 shares directly and 20,196 shares indirectly through a 401(k) plan. The sale was made under a Rule 10b5‑1 trading plan adopted on May 18, 2026.

Insider Trade Summary 10b5-1

Net Seller: 1,100 shares

Net Sell 1 txn

Insider Malady Kyle

Role EVP and Group CEO-VZ Business

Sold 1,100 shs ($55K)

Share of Position Sold 1.0%

Type	Security	Shares	Price	Value
Sale	Common Stock F1	1,100	$49.98	$55K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 106,566 shares (Direct); Common Stock — 20,196 shares (Indirect, By 401(k))

Holdings Before and After: Common Stock, 107,666 to 106,566 shares (Direct)

Footnotes (1)

1. F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Key Figures

Shares sold: 1,100 shares Sale price per share: $49.98 per share Direct holdings after transaction: 106,566 shares +3 more

6 metrics

Shares sold 1,100 shares Sale of Verizon common stock on September 8, 2026

Sale price per share $49.98 per share Open‑market or private sale on September 8, 2026

Direct holdings after transaction 106,566 shares Direct Verizon common stock position after the reported sale

Indirect holdings after transaction 20,196 shares Held indirectly through a 401(k) plan after the reported sale

Total reported holdings after transaction 126,762 shares Sum of direct and indirect holdings following the September 8, 2026 sale

Rule 10b5-1 plan adoption date May 18, 2026 Date Kyle Malady adopted the plan used for this sale

Key Terms

Rule 10b5-1 trading plan, indirectly through a 401(k), open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

indirectly through a 401(k) financial

"After the sale, he held 106,566 shares directly and 20,196 shares indirectly through a 401(k) plan."

open market or private transaction financial

"reported selling 1,100 shares of common stock on September 8, 2026 at $49.98 per share in an open market or private transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VZ executive Kyle Malady report?

Kyle Malady reported a sale of 1,100 shares of Verizon common stock on September 8, 2026 at $49.98 per share in an open‑market or private transaction, executed under a Rule 10b5‑1 trading plan.

How many Verizon (VZ) shares did Kyle Malady retain after the reported sale?

After the sale, Kyle Malady held 106,566 Verizon shares directly and 20,196 shares indirectly through a 401(k) plan, for a total reported holding of 126,762 shares of Verizon common stock.

At what price did the Verizon (VZ) insider shares sell on September 8, 2026?

The reported sale by Kyle Malady on September 8, 2026 was executed at a price of $49.98 per share for 1,100 shares of Verizon common stock.

Was Kyle Malady’s Verizon (VZ) share sale under a Rule 10b5-1 plan?

Yes. The filing states the transaction was executed pursuant to a Rule 10b5‑1 trading plan adopted by Kyle Malady on May 18, 2026, indicating it was pre‑arranged rather than opportunistic.

What is Kyle Malady’s role at Verizon (VZ) in this insider filing?

In this filing, Kyle Malady is identified as an officer of Verizon, serving as Executive Vice President and Group CEO–VZ Business, and he is the reporting person for the disclosed stock transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		S(1)		1,100	D	$49.98	106,566	D
Common Stock								20,196	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2026.

Remarks:

	Evgeniya Berezkina, Attorney-in-fact for Kyle Malady	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)